Xtant Medical Holdings, Inc.

XTNTAMEXUSD
0.46 USD
0.00 (0.91%)AT CLOSE (11:59 AM EDT)
0.46
0.00 (0.20%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
0.46
0.00 (0.20%)
🔴Market: CLOSED
Open?$0.46
High?$0.47
Low?$0.45
Prev. Close?$0.46
Volume?62.9K
Avg. Volume?148.2K
VWAP?$0.46
Rel. Volume?0.42x
Bid / Ask
Bid?$0.45 × 800
Ask?$0.50 × 400
Spread?$0.05
Midpoint?$0.47
Valuation & Ratios
Market Cap?64.5M
Shares Out?140.3M
Float?33.8M
Float %?24.2%
P/E Ratio?35.33
P/B Ratio?1.33
EPS?$0.01
Dividend?0.00%
Ex-Dividend?N/A

Xtant Medical Holdings, Inc. (XTNT) trades at $0.46 per share. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest XTNT is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
Employees
151
Market Cap
64.5M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
2007-01-31
Address
664 CRUISER LANE
BELGRADE, MT 59714
Phone: 406-388-0480
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-2/3)
Medium-Term (Wave)? Bearish(-1/3)
Short-Term (Ripple)? Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
1
Momentum?
3
Short Sent.?
100
Piotroski F-Score?3/9Weak
Altman Z-Score?-0.93Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.06%Low
Short Interest?19.5K
Days to Cover?1.0
Free Float33.8M
Avg Daily Volume159.2K
Settlement Date2026-05-15
Financial Health
Current Ratio?3.33Strong
Quick Ratio?1.64Adequate
Cash Ratio?0.65Adequate
Debt/Equity?0.25Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
89/100
P/E?
Peers
100
S&P
21
35.3PRICEY
P/B?
Peers
100
S&P
91
1.33CHEAP
P/S?
Peers
100
S&P
97
0.53CHEAP
P/FCF?
Peers
100
S&P
93
8.3CHEAP
EV/EBITDA?
Peers
100
S&P
90
8.1CHEAP
EV/Sales?
Peers
100
S&P
97
0.53CHEAP
Returns & Efficiency
ROE?
Peers
50
S&P
18
3.8%WEAK
ROA?
Peers
50
S&P
22
2.3%WEAK
Cash Flow & Enterprise
FCF?$7.8M
Enterprise Value?$64.7M
Fundamentals ratios updated end of day